RWE Oncology Market, By Component, By Data Source Type, By Therapeutic Area, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

RWE oncology market size was valued at US$ 790.10 Million in 2024, expanding at a CAGR of 14.90% from 2025 to 2032.

Real-World Evidence (RWE) in oncology involves the collection and analysis of health data from real-world settings such as electronic health records, patient registries, and insurance claims-to complement clinical trial findings. This evidence supports treatment effectiveness, safety monitoring, and personalized cancer care decisions. The market growth is driven by increasing cancer prevalence and the rising adoption of value-based healthcare models. According to the National Cancer Institute (NCI), an estimated 1.9 million new cancer cases were diagnosed in the U.S. in 2024, intensifying the need for real-world data to improve therapeutic outcomes. Advances in data analytics, AI integration, and regulatory acceptance are fostering RWE applications to accelerate oncology drug development and optimize patient management globally.

RWE Oncology Market- Market Dynamics

Growing adoption of real-world data to enhance oncology treatment outcomes

The rising global cancer burden and the need for personalized, evidence-based oncology care are driving demand for RWE solutions. According to the World Health Organization (WHO), cancer remains a leading cause of death globally, accounting for nearly 10 million deaths in 2024. This has intensified the focus on utilizing real-world data from electronic health records, cancer registries, and claims databases to complement clinical trials, improving treatment effectiveness and safety monitoring. Regulatory agencies like the U.S. FDA increasingly accept RWE to support drug approvals and label expansions, accelerating market adoption. Advances in AI and machine learning facilitate deeper insights from complex oncology data, enabling precision medicine. Furthermore, healthcare payers and providers emphasize value-based care models, leveraging RWE to optimize treatment protocols and reduce costs. Growing investments in health IT infrastructure, particularly in developed and emerging economies, further propel market growth opportunities worldwide.

RWE Oncology Market- Segmentation Analysis:

The Global RWE Oncology Market is segmented on the basis of Component, Data Source Type, Therapeutic Area, Application, End User, and Region.

Based on Component, the market includes Data Sources, Analytics Software, and Services. Data Sources encompass electronic health records (EHRs), cancer registries, claims and billing data, patient-reported outcomes, and genomic databases, providing diverse real-world insights critical for oncology research. Analytics Software leverages AI and machine learning algorithms to analyze complex oncology datasets for treatment effectiveness, safety, and outcome prediction. Services include consulting, data management, and integration, which help healthcare stakeholders implement RWE solutions efficiently. According to the U.S. Office of the National Coordinator for Health Information Technology (ONC), adoption of certified EHR technology reached over 85% among hospitals in 2024, supporting data availability for RWE.

Based on Application, the market covers Drug Development & Clinical Trials, Treatment Optimization, Regulatory & Payer Decision Support, and Market Access & Reimbursement. Drug Development utilizes RWE to complement clinical trials, enabling accelerated approvals and label expansions. Treatment Optimization involves personalizing therapy based on patient data to improve outcomes. Regulatory & Payer Decision Support uses real-world insights for safety monitoring and coverage decisions. Market Access and Reimbursement benefit from RWE by demonstrating treatment value and cost-effectiveness, critical for payer negotiations and formulary inclusion.

RWE Oncology Market- Geographical Insights

The global RWE oncology market shows significant regional variation shaped by healthcare infrastructure, data availability, and regulatory frameworks. North America leads with over 1.9 million new cancer cases projected in the U.S. in 2024, according to the National Cancer Institute (NCI), fueling demand for real-world data to improve treatment outcomes. The FDA's Real-World Evidence Program further accelerates adoption in this region. Europe follows, with the European Cancer Information System reporting nearly 4 million new cancer cases annually, supporting RWE initiatives across major oncology hubs. Asia-Pacific is expected to experience the fastest growth, with China's National Cancer Center estimating 4.8 million new cancer diagnoses in 2023, driving investments in healthcare data infrastructure and digital oncology solutions. Emerging regions such as Latin America and the Middle East benefit from increasing cancer incidence and government efforts to enhance healthcare data collection, presenting new market opportunities.

U.S. RWE Oncology Market- Country Insights

The United States leads the global RWE oncology market, propelled by its advanced healthcare ecosystem, extensive oncology research, and strong regulatory support for real-world data integration. According to the National Cancer Institute (NCI), approximately 1.9 million new cancer cases are expected in the U.S. in 2024, driving urgent demand for enhanced treatment evaluation through real-world evidence. The FDA's Real-World Evidence Program facilitates faster approvals and improved post-market surveillance, strengthening the market's growth. Key players such as Flatiron Health, IQVIA, and Tempus Labs focus on leveraging vast clinical data, AI analytics, and partnerships with leading cancer centers. The U.S.'s robust health IT infrastructure, high healthcare spending exceeding $4.3 trillion in 2023 (CMS), and ongoing innovation in precision oncology make it the focal point for real-world evidence applications in oncology worldwide.

RWE Oncology Market- Competitive Landscape:

The rising emphasis on data-driven oncology treatment and real-world evidence utilization is intensifying competition among key market players. Major companies such as IQVIA, ICON plc, Syneos Health, Parexel, Covance, and Flatiron Health lead by leveraging advanced data analytics platforms, AI integration, and comprehensive oncology data registries. Common strategies include strategic acquisitions to enhance data capabilities, partnerships with pharmaceutical companies for tailored oncology solutions, and expanding global footprints to access diverse patient populations. Investment in cloud-based data management and real-time evidence generation tools is prevalent, enabling faster drug development and regulatory approvals. Additionally, companies are focusing on compliance with evolving data privacy regulations and offering customized solutions to meet oncology research demands, strengthening their competitive positions worldwide.

Recent Developments:

In May 2025, Datavant completed its acquisition of RWE specialist Aetion, combining data connectivity and advanced real world evidence analytics into a unified platform. The expanded ecosystem-spanning over 300 data partners across EHRs, claims, registries, and more-aims to help life sciences and healthcare organizations generate faster, scalable, and actionable evidence across the drug development lifecycle.

In April 2025, Atropos Health partnered with Ontada to integrate Ontada's community oncology real world data into the Atropos Evidence(TM) Network, enhancing RWE use cases for clinicians, researchers, and healthcare leaders. This collaboration aims to improve cancer care protocols, advance precision medicine, and accelerate development of new oncology treatments using high quality real world evidence.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RWE ONCOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

IQVIA
ICON plc
Syneos Health
Parexel International
Covance (Labcorp)
PPD, Inc.
PRA Health Sciences (now part of ICON)
Charles River Laboratories
Medidata Solutions (Dassault Systemes)
Clarivate
Flatiron Health (owned by Roche)
Cerner Corporation (now part of Oracle)
Cota Healthcare
Evidera (PAREXEL)
RealEndeavors
Truven Health Analytics (IBM Watson Health)
Informa Pharma Intelligence
McKesson Corporation
Symphony Health (ICON)
Others

GLOBAL RWE ONCOLOGY MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

Datasets
EMR/HER
Claims
Pharmacy
Cancer Registries
Integrated Datasets
Consulting Services

GLOBAL RWE ONCOLOGY MARKET, BY DATA SOURCE TYPE- MARKET ANALYSIS, 2019 - 2032

Clinical Data
Claims Data
Oncology Registries
Pharmacy Data

GLOBAL RWE ONCOLOGY MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Breast Cancer
Lung Cancer
Prostate Cancer
Hematologic Malignancies
Others

GLOBAL RWE ONCOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Drug Development & Approvals
Market Access & Reimbursement
Post-Market Surveillance
Medical Device Approvals
Others

GLOBAL RWE ONCOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Pharmaceutical, Biotechnology & Medical Device Companies
Healthcare Providers
Healthcare Payers
Others

GLOBAL RWE ONCOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5973

1. RWE Oncology Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. RWE Oncology Market Snippet by Component
- 2.1.2. RWE Oncology Market Snippet by Data Source Type
- 2.1.3. RWE Oncology Market Snippet by Therapeutic Area
- 2.1.4. RWE Oncology Market Snippet by Application
- 2.1.5. RWE Oncology Market Snippet by End User
- 2.1.6. RWE Oncology Market Snippet by Country
- 2.1.7. RWE Oncology Market Snippet by Region
2.2. Competitive Insights

3. RWE Oncology Key Market Trends

3.1. RWE Oncology Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. RWE Oncology Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. RWE Oncology Market Opportunities
3.4. RWE Oncology Market Future Trends

4. RWE Oncology Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. RWE Oncology Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. RWE Oncology Market Landscape

6.1. RWE Oncology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. RWE Oncology Market - By Component

7.1. Overview
- 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
- 7.1.2. Datasets
  - 7.1.2.1. EMR/HER
  - 7.1.2.2. Claims
  - 7.1.2.3. Pharmacy
  - 7.1.2.4. Cancer Registries
- 7.1.3. Integrated Datasets
- 7.1.4. Consulting Services

8. RWE Oncology Market - By Data Source Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Data Source Type, 2024 & 2032 (%)
- 8.1.2. Clinical Data
- 8.1.3. Claims Data
- 8.1.4. Oncology Registries
- 8.1.5. Pharmacy Data

9. RWE Oncology Market - By Therapeutic Area

9.1. Overview
- 9.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
- 9.1.2. Breast Cancer
- 9.1.3. Lung Cancer
- 9.1.4. Prostate Cancer
- 9.1.5. Hematologic Malignancies
- 9.1.6. Others

10. RWE Oncology Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Drug Development & Approvals
- 10.1.3. Market Access & Reimbursement
- 10.1.4. Post-Market Surveillance
- 10.1.5. Medical Device Approvals
- 10.1.6. Others

11. RWE Oncology Market - By End User

11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 11.1.2. Pharmaceutical, Biotechnology & Medical Device Companies
- 11.1.3. Healthcare Providers
- 11.1.4. Healthcare Payers
- 11.1.5. Others

12. RWE Oncology Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. RWE Oncology Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. RWE Oncology Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.18. Rest of Europe
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.18.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.3.18.4. Rest of the Europe Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.3.18.5. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. RWE Oncology Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. RWE Oncology Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. RWE Oncology Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Data Source Type, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- RWE Oncology Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. IQVIA
- 13.2.2. ICON plc
- 13.2.3. Syneos Health
- 13.2.4. Parexel International
- 13.2.5. Covance (Labcorp)
- 13.2.6. PPD, Inc.
- 13.2.7. PRA Health Sciences (now part of ICON)
- 13.2.8. Charles River Laboratories
- 13.2.9. Medidata Solutions (Dassault Systemes)
- 13.2.10. Clarivate
- 13.2.11. Flatiron Health (owned by Roche)
- 13.2.12. Cerner Corporation (now part of Oracle)
- 13.2.13. Cota Healthcare
- 13.2.14. Evidera (PAREXEL)
- 13.2.15. RealEndeavors
- 13.2.16. Truven Health Analytics (IBM Watson Health)
- 13.2.17. Informa Pharma Intelligence
- 13.2.18. McKesson Corporation
- 13.2.19. Symphony Health (ICON)
- 13.2.20. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us